What is PediaMetrix?
Operating within the highly specialized medical devices industry, PediaMetrix is dedicated to transforming pediatric care through the application of sophisticated machine learning and image processing technologies. The company addresses a critical market need by providing both parents and pediatricians with reliable, data-driven diagnostic tools. By digitizing and automating aspects of pediatric health monitoring, PediaMetrix is effectively modernizing the standard of care, moving away from subjective assessments toward objective, evidence-based clinical insights that improve patient outcomes at the point-of-care.
How much funding has PediaMetrix raised?
PediaMetrix has raised a total of $2.2M across 2 funding rounds:
Other Financing Round
$200K
Grant
$2M
Other Financing Round (2024): $200K with participation from Tedco
Grant (2025): $2M led by National Institutes of Health (NIH)
Key Investors in PediaMetrix
National Institutes of Health (NIH)
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, focusing on advancing scientific discovery to improve human health.
Tedco
TEDCO is a Maryland-based organization that fosters an inclusive entrepreneurial innovation ecosystem by investing in and supporting technology and life science-based companies.
What's next for PediaMetrix?
With this major strategic investment, PediaMetrix is poised to transition from its current development phase into a broader commercialization and enterprise-level scaling strategy. The capital will likely be deployed to refine its proprietary diagnostic algorithms and expand its regulatory footprint, ensuring that its digital health solutions meet the rigorous demands of modern healthcare systems. As the company continues to scale, the focus will remain on enhancing the interoperability of its platforms with existing electronic health records, thereby cementing its position as an essential component of the pediatric healthcare infrastructure. Future growth will be defined by the successful integration of these tools into diverse clinical environments, ultimately driving long-term value for stakeholders and improving the quality of life for pediatric patients globally.
See full PediaMetrix company page
